4 products were found matching "Cay10233-%25"!

No results were found for the filter!
MK-886 (sodium salt)
MK-886 (sodium salt)

Item number: Cay10133-25

Arachidonic acid (Cay-90010) and selected other polyunsaturated fatty acids are stereoselectively oxygenated at carbon 5 by the non-heme iron containing enzyme 5-lipoxygenase (5-LO). The intervention of a second protein, 5-LO-activating protein (FLAP), is required before 5-LO can become catalytically active. MK-886...
Keywords: 1-[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-alpha,alpha-dimethyl-5-(1-methylethyl)-1H-indole-2-propanoic acid,...
Application: Leukotriene biosynthesis inhibitor
CAS 118427-55-7
MW: 494.1 D
From 43.00€ *
Review
Lipoxin A4 methyl ester
Lipoxin A4 methyl ester

Item number: Cay10033-25

Lipoxin A4 (LXA4) methyl ester is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4. LXA4 is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of 15-HETE or 15-HpETE with human leukocytes. LXA4 is equipotent to leukotriene B4 (LTB4) in inducing...
Keywords: 5(S),6(R),15(S)-TriHETE methyl ester, LXA4 methyl ester, 5S,6R,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid, methyl...
Application: Bioactive lipid assays
CAS 97643-35-1
MW: 366.5 D
From 368.00€ *
Review
Lipid-based Drug Delivery Tools
1,2-Didocosahexaenoyl-sn-glycero-3-PC
1,2-Didocosahexaenoyl-sn-glycero-3-PC

Item number: Cay10733-25

1,2-Didocosahexaenoyl-sn-glycero-3-PC is a phospholipid that contains docosahexaenoic acid (Cay-90310, Cay-17950) at the sn-1 and sn-2 positions. It has been used in the formation of polyunsaturated endoplasmic reticulum-targeting liposomes (PERLs) that reduce cellular cholesterol levels in human peripheral blood...
Keywords: 1,2-Didocosahexaenoin-sn-glycero-3-Phosphatidylcholine, 1,2-Didocosahexaenoyl PC,...
Application: Phospholipid
CAS 99296-81-8
MW: 878.2 D
From 84.00€ *
Review
SBC-110736
SBC-110736

Item number: Cay23103-25

SBC-110736 is an inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9). It increases LDL receptor (LDLR) levels in HepG2 cells expressing PCSK9 when used at a concentration of 400 nM. SBC-110736 (8 mg/kg per day) reduces plasma total cholesterol levels by a mean of 38% in mice fed a high-fat diet. It...
Keywords: N-[4-[[4-(4-methylphenyl)-2-phenyl-1-piperazinyl]carbonyl]phenyl]-acetamide
Application: PCSK9 inhibitor
CAS 1629166-02-4
MW: 413.5 D
From 50.00€ *
Review